News

West Pharmaceutical Services’ first quarter results drew a negative market response, despite the company surpassing Wall ...
West Pharmaceutical Services beat analysts’ revenue expectations by 1.2% last quarter, reporting revenues of $748.8 million, up 2.3% year on year. It was a softer quarter for the company, ...
Pharmaceutical partners are now repeatedly seeking to become integrated care providers, wanting to play a bigger supporting role and thus are investing in services alongside their product offering.
West Pharmaceutical Services Inc. closed 38.11% below its 52-week high of $352.33, which the company reached on October 24th.
Kennedy said that Pallone had previously been a champion of people who had been harmed by vaccines and only changed his tune ...
Trump's NIH cuts are gutting university labs that fuel Big Pharma's drug pipeline and pushing U.S. biotech jobs, research, ...
A high-level overview of West Pharmaceutical Services, Inc. (WST) stock. View (WST) real-time stock price, chart, news, analysis, analyst reviews and more.
Pharma companies are expending considerable time, energy and money on developing services that are designed to support patients before, during and after treatment across therapeutic areas.
RFK Jr. is attempting to curb pharma ad spending, according to Bloomberg. One expert and former senior HHS official thinks ...
Review the current West Pharmaceutical Services Inc (WST:XNYS) growth, profitability and efficiency, financial health, and cash flow key metrics to decide if WST is the best investment for you.
West Pharmaceutical Services, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - WST PR Newswire Jun 23, 2025, 1:00:00 PM ...